Company overview
Yourgene Health, part of the Novacyt group, develops, manufactures, and sells molecular diagnostic products and services focused on reproductive health and precision medicine, including NIPT workflows, cystic fibrosis screening, aneuploidy tests, and DPYD genotyping assays. The company offers genomic testing services for pharma, biotech, and central labs supporting clinical studies from Phase I to III under GCP, CLIA, and ISO15189 compliance. Products like LightBench Detect enable fetal fraction enrichment for NIPT, reducing no-call rates and costs in liquid biopsy workflows.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://yourgenehealth.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- molecular diagnostics, nipt workflows, genomic services, precision medicine, reproductive health
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What molecular diagnostics solutions does Yourgene Health offer for reproductive health?
- Yourgene Health provides non-invasive prenatal tests (NIPT) NGS workflows, cystic fibrosis screening, aneuploidy tests, and fetal fraction enrichment solutions like LightBench Detect to optimize NIPT outcomes and reduce no-call rates.
- What regulatory compliances do Yourgene Health's genomic services meet?
- Yourgene Genomic Services comply with GCP, CLIA, and ISO15189 standards, supporting clinical studies from Phase I to III for pharma and biotech.
- In which geographies does Yourgene Health operate?
- Headquartered in the UK, Yourgene Health provides screening solutions in more than 65 countries worldwide.
Related editorial coverage
- Bio-IT World Conference: Oncology Highlights - Day 1
- BioMed Israel 2024: Key Innovations and US Partnerships
- US-Japan Healthcare Conf: Key Takeaways for 2026
- Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- Brazilian Oncology Market: Growth of Precision Medicine & Biomarker Testing
Explore lab tools and QA/QC resources for R&D teams.
